By Deandra Grant & Griffin Grant
Welcome to The Defense File where we examine the criminal cases of public figures through the lens of Texas criminal law. Each entry looks at what happened in court, what the defense argued, and what a defendant would have faced (and how they might have been defended) if the same facts had occurred in Texas.
Tiger Woods has now been arrested for DUI twice in Florida. Both times, his blood alcohol content was zero. Both times, the case centered entirely on prescription medications and whether those medications impaired his ability to drive. The 2017 case resulted in a favorable plea to reckless driving. The 2026 case (filed just weeks ago) is pending, and the evidentiary foundation is even thinner: no chemical test result at all.
Taken together, the two cases are the most instructive real-world examples available of how prescription drug DWI cases are built by prosecutors, challenged by defense attorneys and what the same facts would produce in Texas.
The 2017 Arrest: Five Drugs, Zero Alcohol
On May 29, 2017, Jupiter police found Woods asleep at the wheel of his Mercedes-Benz, parked on the roadside with flat tires and minor damage. He was disoriented, slurring words, and unable to identify his location. A breathalyzer registered 0.000. A subsequent toxicology report revealed five substances in his system: hydrocodone (Vicodin), hydromorphone (Dilaudid), zolpidem (Ambien), alprazolam (Xanax), and THC. Woods attributed the episode to an unexpected reaction to prescribed medications following his fourth back surgery weeks earlier.
The case was filed in Palm Beach County. Woods pleaded not guilty initially. On October 27, 2017, he pleaded guilty to a lesser offense of reckless driving as part of a first-offender diversion program. He received 12 months of probation, a $250 fine, 50 hours of community service, DUI school, and a victim impact workshop. The DUI charge was dropped. Upon successful completion of the diversion program in 2018, the reckless driving charge was expunged.
The 2026 Arrest: One Drug, Zero Breathalyzer, No Test
On March 27, 2026 (just days before the Masters) Woods was arrested in Martin County, Florida, after his Land Rover struck a trailer truck and rolled over. He told deputies at the scene that he had looked down at his phone and did not realize the truck ahead had slowed. He climbed out of the rolled vehicle and was arrested at the scene.
The breathalyzer registered triple zeros. Officers noted physical signs of impairment: bloodshot eyes and extremely dilated pupils. Woods told a deputy that he takes “a few” prescription medications and had taken them that morning. Two hydrocodone pills were found in his pocket. He refused to submit to a urine test at the jail.
He was charged with misdemeanor DUI with property damage and a separate misdemeanor charge of refusal to submit to a lawful test. He pleaded not guilty. A judge approved his request to seek treatment outside the United States, citing privacy concerns. The 2026 case is pending.
The Evidentiary Problem in the 2026 Case
The prosecution’s 2026 case is built on three things: officer observations of physical impairment, Woods’ own statement that he took prescription medications that morning, and two hydrocodone pills found in his pocket. There is no chemical test result confirming any substance in his system at the time of the crash. The refusal to take the urine test eliminated the prosecution’s strongest piece of evidence and created a second charge.
The prosecution must prove, beyond a reasonable doubt, that Woods was impaired at the time he was driving. Without a blood or urine test result, the prosecution’s case is built entirely on:
- Officer observations. Bloodshot eyes, extremely dilated pupils, and physical signs observed at the scene. These are the same indicators an officer would document in any DUI stop. Without a chemical test, they carry the full weight of the impairment case.
- Woods’ own admission. He told a deputy he had taken “a few” prescription medications that morning. This admission is admissible and places drugs in his system on the day of the crash. It does not establish what the concentration was, whether that concentration was at an impairing level at the time of driving, or whether the physical signs the officer observed were caused by the medication rather than by the trauma of a rollover crash.
- Hydrocodone pills in his pocket. Two pills found on his person establish that he possessed the medication. They do not establish that he had consumed a dose sufficient to cause impairment, or that impairment from that medication produced the crash.
The refusal to test is a double-edged strategic decision. By refusing the urine test, Woods’ defense eliminated the evidence that would most directly establish the type and concentration of any substance in his system at the time of driving. That eliminated the prosecution’s ability to prove the drug concentration element. But the refusal is itself admissible in a Florida DUI trial as circumstantial evidence of consciousness of guilt, and it generated a separate misdemeanor charge. The defense traded one type of evidence problem for two others.
The Texas Analysis: Both Cases
The DUID Framework: Texas Penal Code §49.04
Both incidents would be charged in Texas under the impairment prong of the DWI definition: not having the normal use of mental or physical faculties by reason of the introduction of a drug or controlled substance. Texas has no per se legal limit for any prescription medication. The prosecution must prove actual impairment of normal faculties at the time of driving and not merely the presence of a substance in the body.
Presence is not impairment. This is the central defense argument in every prescription drug DWI case, and it applies with particular force in the 2026 case where there is no chemical test result at all. Hydrocodone in a person’s pocket does not prove it was in their system. Even if it was in their system, presence does not establish the concentration. Even if the concentration was measurable, the concentration must be shown to have produced impairment of normal faculties at the time of driving and not merely the time of the officer’s observation.
The 2017 Five-Drug Case in Texas
In 2017, Woods had a toxicology report confirming five substances in his system: two opioid painkillers, a benzodiazepine, a sleep aid, and THC. In Texas, a blood draw taken pursuant to a DWI arrest would likely be analyzed by LC-MS/MS (liquid chromatography-tandem mass spectrometry) for controlled substances. A positive result for multiple CNS depressants would be presented to a jury as evidence of impairment.
The defense in a Texas case with this toxicology would focus on pharmacokinetics: what concentration of each substance was present, whether the combination produced additive or synergistic effects, and whether those effects (at the measured concentrations) actually impaired his normal faculties. Deandra Grant’s Master’s Degree in Pharmaceutical Science and Graduate Certificate in Forensic Toxicology apply directly. The defense would retain an independent pharmacologist to evaluate the concentration data and testify about the therapeutic vs. impairing range for each substance. The interaction effects between opioids, benzodiazepines, and zolpidem are a pharmacology question that requires expert testimony to address effectively.
The 2017 Florida resolution (reckless driving, diversion, expungement) would not automatically be available in Texas. Texas does not have a general DWI diversion program equivalent to Florida’s first-offender program. Deferred adjudication for DWI became available in 2023 only for first-offense cases with no prior DWI convictions and a BAC below 0.15%. The five-drug toxicology in 2017 would fit within that framework, and the negotiating path to a reckless driving reduction (as Vince Young’s case illustrated) depends heavily on the strength of the prosecution’s evidence and the specific prosecutor’s charging philosophy.
The 2026 No-Test Case in Texas
The 2026 case presents a different evidentiary profile. In Texas, a DWI defendant who refuses a chemical test following a lawful arrest triggers an Administrative License Revocation proceeding: a license suspension follows unless an ALR hearing is requested within 15 days of notice of suspension, and the refusal is admissible in any subsequent DWI trial as evidence of consciousness of guilt. Note: In most jurisdictions in Texas the police would have obtained a blood search warrant and had blood drawn in this case.
But without a chemical test result, the prosecution’s DWI case in Texas rests entirely on officer observations and the defendant’s own statements. In a jury trial, that evidence is subject to the following challenges:
- The crash trauma alternative explanation. A person who has just been in a rollover crash (whose vehicle struck a truck and flipped over) will present with physiological signs that closely mimic drug impairment: disorientation, unsteady gait, bloodshot eyes, dilated pupils, and slurred or confused speech. These are documented responses to trauma, adrenaline, and shock. The defense develops this alternative explanation with medical expert testimony on the physiological effects of vehicle crash trauma.
- The phone distraction as the crash cause. Woods told officers at the scene that he looked down at his phone and did not realize the truck ahead had slowed. If the crash was caused by distraction rather than impairment (a factually separate question) the prosecution’s theory that impairment caused the crash is undermined.
- Absence of concentration evidence. Two pills in a pocket do not establish ingestion. Even if ingested, the timing of a hydrocodone dose relative to its peak concentration and the impairment threshold is a pharmacokinetic question that requires expert testimony. The prosecution’s case asks a jury to infer impairment from observable signs alone, without the chemical test result that would most directly support that inference.
- Article 38.23. In Texas, the defense examines the lawfulness of the initial stop or approach, the basis for the arrest decision, and whether any evidence was obtained through unlawful means. In a crash scene investigation, the officer’s authority to conduct the investigation and test the driver is well established. But the chain of events from initial contact through the arrest decision is reviewed for any constitutional deviation.
The Prior Conviction Enhancement Question
Here is a Texas-specific point that matters if the 2026 case produces a conviction: the 2017 Florida reckless driving plea would not count as a prior DWI conviction for enhancement purposes in Texas. Texas Penal Code §49.09 requires a prior conviction for a DWI offense under §49.04 or its equivalents in other jurisdictions. Florida’s reckless driving charge is not equivalent to a DWI offense. It is a traffic offense, not an impaired driving conviction.
This means that if the 2026 DUI arrest had occurred in Texas, and if it resulted in a DWI conviction, it would be charged as a first-offense Class B misdemeanor and not a second-offense Class A misdemeanor. The 2017 expunged reckless driving plea does not enhance the 2026 charge in Texas. The enhancement ladder in Texas requires prior DWI convictions specifically, not prior traffic or reckless driving convictions.
What the Two Cases Illustrate About Prescription Drug DWI
The Woods cases, taken together, are a near-perfect illustration of how prescription drug DWI prosecutions work and why they are genuinely more defensible than alcohol DWI cases:
- There is no legal limit for prescription medications. The prosecution must prove actual impairment of normal faculties.
- Without a chemical test result, the prosecution has no direct evidence of what substance was in the defendant’s system or at what concentration.
- Physical impairment signs are non-specific. They are consistent with drug impairment but also consistent with the trauma of a vehicle crash, fatigue, illness, and numerous other conditions.
- The pharmacokinetics of prescription opioids (timing of ingestion, peak concentration, therapeutic vs. impairing dose ranges) require expert testimony that generic DWI prosecution witnesses are not equipped to provide.
For anyone in Texas facing a DWI case involving prescription medications (ex. opioids, benzodiazepines, sleep aids, muscle relaxants, or any combination) the defense analysis begins with the presence vs. impairment distinction and requires pharmaceutical science expertise to develop effectively.
Related Reading on Deandra Grant Law
- I Took a Prescription Drug. Can I Be Charged with DWI? — The presence vs. impairment distinction, DRE protocol, and how prescription drug cases are prosecuted in Texas.
- Todd Helton’s DUI Cases: Ambien and What Texas Would Have Done — The sleep-driving FDA black box warning and the involuntary intoxication question.
- DWI Defense in Texas — The per se and impairment definitions of intoxication, chemical test challenges, and the ALR deadline.
Sources
- Fox News — Tiger Woods 2026 body cam footage: foxnews.com
- Yahoo Sports / The Sporting News — 2026 charges explained: sports.yahoo.com
- NBC News — Judge approves treatment outside U.S.: nbcnews.com
- Yahoo Sports — 2026 Masters and DUI arrest context: sports.yahoo.com
- Palm Beach Post — Tiger Woods 2017 DUI arrest and plea: palmbeachpost.com
- Texas Penal Code §49.04 and §49.09 — DWI and enhancement: statutes.capitol.texas.gov
- FDA — Hydrocodone prescribing information and warnings: fda.gov
- The Defense File is an educational series. The 2026 case is pending. All Texas analysis is hypothetical and does not constitute legal advice about any specific case.
If you are facing DWI charges in Texas involving prescription medications, call (214) 225-7117 for a free, confidential consultation. The presence vs. impairment distinction is the central defense argument in every prescription drug DWI case — and it requires pharmaceutical science expertise to pursue effectively. Or schedule online at texasdwisite.com.